Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VYCOR MEDICAL INCVYCO · Entity 8497 | Director · Chief Executive Officer | March 22, 2019 | July 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VYCOR MEDICAL INC
Report date March 22, 2019 · Filed July 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,856 |
Reported balance
Holding disclosure · report date 2019-03-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 48,856 |
| Series D Preferred StockSEC Table I · non-derivative | Direct | 69,487 |
Reported balance
Holding disclosure · report date 2019-03-22 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 69,487 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 20, 2018 Filed Apr 24, 2018 14:32 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 161,598 | $0.43 Strike: $0.30 | $69,487.14 |
DisclosureSEC source: 0001493152-18-005697 · form4.xml · derivative · entry 4 ZACHARIOU PETER C · CIK 0001066102 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 161,598 shares Expires 2020-08-04 F1 · kind: Cashless exercise of 161,598 Warrants to purchase common stock at $0.30 per share. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 14:32 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherCommon Stock | 48,856 | $0.43 | $21,008.08 |
DisclosureSEC source: 0001493152-18-005697 · form4.xml · nonDerivative · entry 1 ZACHARIOU PETER C · CIK 0001066102 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,856 F1 · kind: Cashless exercise of 161,598 Warrants to purchase common stock at $0.30 per share. Read SEC document |
| August 05, 2017 Filed Sep 15, 2017 15:02 UTC | VYCOR MEDICAL INC VYCO · Entity 8497 | OtherWarrant · Derivative | 161,598 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001493152-17-010660 · form4.xml · derivative · entry 3 ZACHARIOU PETER C · CIK 0001066102 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,598 Underlying: Common Stock · 161,598 shares Expires 2020-08-04 F1 · kind: Warrants issued pursuant to Share Exchange Agreement dated August 5, 2014 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.